Aerovate Therapeutics
AVTE
#9229
Rank
โ‚น6.32 B
Marketcap
โ‚น218.14
Share price
0.40%
Change (1 day)
-90.11%
Change (1 year)

Aerovate Therapeutics (AVTE) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น6.77 Billion

According to Aerovate Therapeutics's latest financial reports the company has โ‚น6.77 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Aerovate Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น10.19 B-4.68%
2022-12-31โ‚น10.69 B-14.17%
2021-12-31โ‚น12.45 B3624.99%
2020-12-31โ‚น0.33 B33.46%
2019-12-31โ‚น0.25 B